• name

  Proniras Corporation

• homepage url

  proniras.com

• crunchbase url

  proniras-corp

• employee count

  1

• sector

  Healthcare & Health Services

• industry

  Biotechnology

Description

Proniras Corporation is a clinical-stage biotechnology company developing novel small-molecule therapeutics for the treatment of substance use and specialty central nervous system disorders. Its lead program, PRN-001-01 (tezampanel), is being clinically developed as a treatment option for opioid withdrawal and related disorders of addiction.